Genome Engineering of Hematopoietic Stem Cells Using CRISPR/Cas9 System
- 5 May 2022
- book chapter
- Published by Springer Nature
- Vol. 2429, 307-331
Abstract
Ex vivo genetic manipulation of autologous hematopoietic stem and progenitor cells (HSPCs) is a viable strategy for the treatment of hematologic and primary immune disorders. Targeted genome editing of HSPCs using the CRISPR-Cas9 system provides an effective platform to edit the desired genomic locus for therapeutic purposes with minimal off-target effects. In this chapter, we describe the detailed methodology for the CRISPR-Cas9 mediated gene knockout, deletion, addition, and correction in human HSPCs by viral and nonviral approaches. We also present a comprehensive protocol for the analysis of genome modified HSPCs toward the erythroid and megakaryocyte lineage in vitro and the long-term multilineage reconstitution capacity in the recently developed NBSGW mouse model that supports human erythropoiesis.Keywords
This publication has 26 references indexed in Scilit:
- Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor deliveryNucleic Acids Research, 2017
- Murine Hind Limb Long Bone Dissection and Bone Marrow IsolationJournal of Visualized Experiments, 2016
- Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG miceScientific Reports, 2016
- Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNANature Biotechnology, 2016
- CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplantsBritish Journal of Haematology, 2015
- Nonirradiated NOD,B6.SCID Il2rγ−/− KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic CellsStem Cell Reports, 2015
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleasesNature Biotechnology, 2014
- Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNAJournal of Visualized Experiments, 2014
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingNature Biotechnology, 2014
- Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) MicePLOS ONE, 2011